Literature DB >> 8653868

Leukocyte depletion attenuates reperfusion injury in patients with left ventricular hypertrophy.

Y Sawa1, K Taniguchi, K Kadoba, M Nishimura, H Ichikawa, A Amemiya, T Kuratani, H Matsuda.   

Abstract

BACKGROUND: Reperfusion injury can occur after a long period of aortic cross-clamping in patients with left ventricular hypertrophy during open-heart surgery, even with the most up-to-date techniques of myocardial protection. In the present study, we examined whether leukocyte depletion as an adjunct to terminal blood cardioplegia (LDTC) attenuates reperfusion injury in patients with left ventricular hypertrophy (LV mass, >300 g; left ventricular end-systolic volume index, >100 mL/m2) in a group of 30 patients undergoing aortic valve replacement. METHODS AND
RESULTS: We used basic cold potassium crystalloid cardioplegic solution. Terminal blood cardioplegic solution (TC) or LDTC was accomplished by mixing a cold potassium crystalloid cardioplegic solution with warm arterial blood obtained through cardiopulmonary bypass and administered to the aortic root for the first 10 minutes of reperfusion. During delivery of LDTC, warm arterial blood was passed through a leukocyte-removal filter. Patients were randomized into one of three groups for reperfusion: whole blood (WB) (n=10), TC (n=10), and LDTC (n=10). Left ventricular biopsies were obtained before ischemia, at the end of ischemia, and 15 minutes after reperfusion. Semiquantitative scoring for ultrastructural alterations indicated that the LDTC group achieved significantly better recoveries of both scores at reperfusion for myocyte damage and for endothelial cell damage of capillaries than did the WB and TC groups. The LDTC group had significantly fewer neutrophils adhering to endothelial cells at reperfusion and a lower level of malondialdehyde derived from myocardium than did the WB and TC groups. Regarding the clinical data, the LDTC group had a lower maximum creatine kinase-MB, a higher percentage of spontaneous defibrillation, a lower pulmonary capillary wedge pressure, and a lower requirement for dopamine that did the WB group, whereas the TC group failed to do better than the WB group.
CONCLUSIONS: These results demonstrate that leukocyte-depleted reperfusion is potentially beneficial as an adjunct to terminal cardioplegia during cardiac surgery to attenuate reperfusion injury in patients with left ventricular hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8653868     DOI: 10.1161/01.cir.93.9.1640

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

1.  Controlled reperfusion.

Authors:  Hajime Ichikawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-02-12

2.  Uric acid promotes an acute inflammatory response to sterile cell death in mice.

Authors:  Hajime Kono; Chun-Jen Chen; Fernando Ontiveros; Kenneth L Rock
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

Review 3.  From trash to leucocytes: what are we filtering and why?

Authors:  Simon J Mitchell
Journal:  J Extra Corpor Technol       Date:  2006-03

4.  Uric acid as a novel biomarker for bone-marrow function and incipient hematopoietic reconstitution after aplasia in patients with hematologic malignancies.

Authors:  Sebastian P Haen; Vicky Eyb; Nora Mirza; Aline Naumann; Andreas Peter; Markus W Löffler; Christoph Faul; Wichard Vogel; Wolfgang A Bethge; Hans-Georg Rammensee; Lothar Kanz; Martin Heni
Journal:  J Cancer Res Clin Oncol       Date:  2017-02-16       Impact factor: 4.553

Review 5.  Use of leukocyte-depleting filters during cardiac surgery with cardiopulmonary bypass: a review.

Authors:  Shalini Boodram; Ed Evans
Journal:  J Extra Corpor Technol       Date:  2008-03

6.  First brain dead donor heart transplantation under new legislation in Japan.

Authors:  H Matsuda; N Fukushima; Y Sawa; M Nishimura; G Matsumiya; R Shirakura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-10

7.  Concomitant aortic root remodeling and coronary bypass in a patient with poor left ventricular function.

Authors:  S Fukushima; T Takahashi; M Nishimura; S Ohtake; Y Sawa; H Matsuda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-08

8.  Efficacy of leukocyte-depleted terminal blood cardioplegia in congenital heart disease.

Authors:  H Yamauchi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-07

Review 9.  Cardioplegic strategies to protect the hypertrophic heart during cardiac surgery.

Authors:  M-S Suleiman; M Hancock; R Shukla; C Rajakaruna; G D Angelini
Journal:  Perfusion       Date:  2011-09       Impact factor: 1.972

10.  Eprosartan improves cardiac function in swine working heart model of ischemia-reperfusion injury.

Authors:  Alexander Weymann; Anton Sabashnikov; Nikhil P Patil; Wolfgang Konertz; Diethelm Modersohn; Pascal M Dohmen
Journal:  Med Sci Monit Basic Res       Date:  2014-04-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.